Effect of Calcium on Gleevec Pharmacokinetics (PK) in Healthy Volunteers

Summary

This research study is being conducted through the University of Pittsburgh Cancer Institute (UPCI). It will evaluate the concentrations of Gleevec®, an oral drug used to treat some types of cancer, in the blood of healthy volunteers when taken with and without Tums Ultra®, a calcium product often used in the treatment of upset stomach and as a calcium supplement.

Timeline

Start

2008-11

Primary completion

2012-11

Completion

2012-12

Drugs

Indications

No indication recorded.